article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

726/2004, 09 March 2021. 726/2004 , which essentially means duplicate MAAs for products authorized via the centralized procedure. World Health Organization (WHO). Falsified COVID-19 vaccines pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities. This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

In addition, it contains essential recommendations to avoid complications and protect public health. Aimed at both consumers and professionals of aesthetic clinics, the alert clarifies the precautionary ban on certain products.

FDA 40